Skip to main content

Table 4 Prevalence of drug use and number of drugs used by gender

From: Adverse childhood experiences among patients with substance use disorders at a referral psychiatric hospital in Kenya

Type of Drug

Overall (N = 134)

Females (n = 16)

Males (n = 118)

 

n

Prevalence (95% C.I)

n

Prevalence (95% C.I)

n

Prevalence (95% C.I)

Lifetime use (Ever used)

 Tobacco

113

84.3 (78.4–90.3)

14

87.5 (68.8–100.0)

99

83.9 (77.1–90.7)

 Alcohol

123

91.8 (87.3–96.3)

14

87.5 (68.8–100.0)

109

92.4 (87.3–97.4)

 Cannabis

86

64.2 (56.0–72.4)

13

81.3 (62.5–100.0)

73

61.9 (53.4–70.3)

 Cocaine

7

5.2 (2.2–9.0)

2

12.5 (0.0–31.3)

5

4.2 (0.8–8.5)

 Amphetamine

4

3.0 (0.7–6.0)

0

0.0 (0.0–0.0)

4

3.4 (0.8–6.8)

 Inhalants

7

5.2 (1.5–9.0)

0

0.0 (0.0–0.0)

7

5.9 (1.7–10.2)

 Sedatives

30

22.4 (15.7–29.1)

4

25.0 (6.3–50.0)

26

22.0 (15.3–30.5)

 Hallucinogen

5

3.7 (0.7–7.4)

1

6.3 (0.0–18.8)

4

3.4 (0.8–6.8)

 Opioids

11

8.2 (3.7–13.4)

5

31.3 (12.5–56.3)

6

5.1 (1.7–9.3)

 Khat

74

55.2 (47.0–64.2)

11

68.8 (43.8–93.8)

63

53.4 (44.9–61.9)

Current use (Past 3 months)

 Tobacco

100

74.6 (67.2–82.1)

13

81.3 (62.5–100.0)

87

73.7 (66.1–81.4)

 Alcohol

110

82.1 (75.4–88.8)

13

81.3 (62.5–100.0)

97

82.2 (74.6–89.0)

 Cannabis

76

56.7 (49.3–64.9)

11

68.8 (43.8–93.6)

65

55.1 (46.6–64.4)

 Cocaine

5

3.7 (0.7–7.5)

0

0.0 (0.0–0.0)

5

4.2 (0.8–8.5)

 Amphetamine

3

2.2 (0.0–5.2)

0

0.0 (0.0–0.0)

3

2.5 (0.0–5.9)

 Inhalants

5

3.7 (0.7–7.4)

0

0.0 (0.0–0.0)

5

4.2 (0.8–7.6)

 Sedatives

19

14.2 (8.2–20.1)

1

6.3 (0.0–18.8)

18

15.3 (9.3–22.0)

 Hallucinogen

3

2.2 (0.0–4.5)

0

0.0 (0.0–0.0)

3

2.5 (0.0–5.9)

 Opioids

6

4.5 (1.5–8.2)

3

18.8 (0.0–37.5)

3

2.5 (0.0–5.9)

 Khat

62

46.3 (38.1–55.2)

9

56.3 (31.3–81.3)

53

44.9 (36.4–53.4)

Number of drugs currently using

 1.00

13

9.7 (5.2–14.9)

2

12.5 (0.0–31.3)

11

9.3 (4.2–15.3)

 2.00

31

23.1 (15.7–29.9)

5

31.3 (12.5–56.3)

26

22.0 (14.4–29.7)

 3.00

35

26.1 (18.7–34.3)

0

0.0 (0.0–0.0)

35

29.7 (21.2–38.1)

 4.00

36

26.9 (20.1–34.3)

6

37.5 (12.5–62.5)

30

25.4 (17.8–33.1)

 5 and Above

19

14.2 (9.0–20.1)

3

18.8 (0.0–43.6)

16

13.6 (7.6–19.5)